Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
PLoS One
2009 Jun 03;46:e5778. doi: 10.1371/journal.pone.0005778.
Show Gene links
Show Anatomy links
Paleo-immunology: evidence consistent with insertion of a primordial herpes virus-like element in the origins of acquired immunity.
Dreyfus DH
.
???displayArticle.abstract???
BACKGROUND: The RAG encoded proteins, RAG-1 and RAG-2 regulate site-specific recombination events in somatic immune B- and T-lymphocytes to generate the acquired immune repertoire. Catalytic activities of the RAG proteins are related to the recombinase functions of a pre-existing mobile DNA element in the DDE recombinase/RNAse H family, sometimes termed the "RAG transposon".
METHODOLOGY/PRINCIPAL FINDINGS: Novel to this work is the suggestion that the DDE recombinase responsible for the origins of acquired immunity was encoded by a primordial herpes virus, rather than a "RAG transposon." A subsequent "arms race" between immunity to herpes infection and the immune system obscured primary amino acid similarities between herpes and immune system proteins but preserved regulatory, structural and functional similarities between the respective recombinase proteins. In support of this hypothesis, evidence is reviewed from previous published data that a modern herpes virus protein family with properties of a viral recombinase is co-regulated with both RAG-1 and RAG-2 by closely linked cis-acting co-regulatory sequences. Structural and functional similarity is also reviewed between the putative herpes recombinase and both DDE site of the RAG-1 protein and another DDE/RNAse H family nuclease, the Argonaute protein component of RISC (RNA induced silencing complex).
CONCLUSIONS/SIGNIFICANCE: A "co-regulatory" model of the origins of V(D)J recombination and the acquired immune system can account for the observed linked genomic structure of RAG-1 and RAG-2 in non-vertebrate organisms such as the sea urchin that lack an acquired immune system and V(D)J recombination. Initially the regulated expression of a viral recombinase in immune cells may have been positively selected by its ability to stimulate innate immunity to herpes virus infection rather than V(D)J recombination Unlike the "RAG-transposon" hypothesis, the proposed model can be readily tested by comparative functional analysis of herpes virus replication and V(D)J recombination.
???displayArticle.pubmedLink???
19492059
???displayArticle.pmcLink???PMC2686171 ???displayArticle.link???PLoS One ???displayArticle.grants???[+]
Figure 1. Mechanism of Tc element transposition, herpes recombination and V(D)J recombination suggests homologous adaptation of a primordial DDE recombinase.Recombination sites of all of these DNA elements are adjacent to a sequence containing a sequence resembling the V(D)J heptamer (bold type) and nonamer sequences (underlined). Nonamer sequences are often spaced at 12 or 23 nucleotide intervals to facilitate DNA bending. Sequences shown from top to bottom: invertebrate Tc elements Tc1, Tc3, EBV terminal repeat sequences, herpes simplex recombination sites, V(D)J RSS and transib transposon termini (Tsib) most closely related to V(D)J RSS among tranposons.
Figure 2. The complete sequence of an EBV terminal repeat defined by the SauIII restriction enzyme is shown with putative V(D)J-like regions and Sp1 transcription factor binding sites identified.Location of V(D)J-like sequences in EBV terminal repeats adjacent to experimentally confirmed Sp1 protein binding sites. Specific protein complexes distinct from Sp1 are also evident on the EBV V(D)J-like sequences shown , and these sequences undergo anomalous migration on native polyacrylamide gels typical of bent DNA similar to the V(D)J RSS and to transposon termini (unpublished observations).
Figure 3. The “big bang” or “RAG-transposon insertion model” of the origins of the acquired immune system.As shown , a transposon inserted at a site in the genome denoted Site A can transcribe an mRNA encoding a bi-molecular transposase consisting of RAG-1 and RAG-2 like proteins from promoters in flanking sequences. Expression of the transposase then can excise a transposon from site A or another site (large arrows) at the transposon termini and insert the transposon and another site termed site B with an immunoglobulin or T-cell receptor gene. Subsequent excision of V(D)J RSS that resemble transposon termini results in circular episomes and repaired empty sites in immunoglobulin and T cell receptor genes. Multiple cycles of RAG transposon insertion and excision from primordial immunoglobulin and T-cell receptor like genes and insertion of the RAG transposon at other sites in the genome such as the current RAG locus with subsequent gene amplification of the immunoglobulin and T cell receptor gene families could result in the current structure of these genetic loci.
Figure 4. The Co-regulatory model including initial insertion of a primordial herpes virus recombinase (proto-RAG-1 denoted pR1) adjacent to a pre-existing RAG-2 like protein (denoted pR2) is shown.As shown, insertion of a herpes virus episome or linear genome adjacent to a RAG-2 like gene would provide a master co-regulated RAG-2/RAG-2 locus acting subsequently through co-evolving slave RSS sites in immunoglobulin or T-cell receptor genes. Co-evolving slave RSS could arise either from additional herpes or transposon insertions and gene duplication events or from co-evolution of endogenous sequences with some similarity to transposon or herpes virus termini in other genes such as those encoding B- and T-lymphocyte receptors (Figure 1). In contrast to the “RAG transposon” model, the co-regulatory model does not require the existence of a composite RAG-1/RAG-2 transposase or transposon and can also account for the experimental structure of the current RAG-1/RAG-2-like genes in the sea urchin and other deuterostomes that do not undergo V(D)J recombination.
Figure 5. Shared somatic regulation between the EBV DBP BALF-2 protein gene and RAG.As shown, a 200 NT 5′ region immediately adjacent to EBV BALF-2 ORF AUG start codon contains putative regulatory sequences for BZLF-1/AP-1 (denoted with a single asterisk), CREB (denoted with a double asterisk**), and SP1 (denoted with a triple asterisk***). These putative regulatory sequences are enclosed in boxes in the figure and include sequences recognized by the EBV encoded BZLF-1 regulatory protein (also termed ZEBRA protein). BZLF-1 sites also are also functional as sites for the endogenous regulatory factor AP-1 as discussed in the text. BZLF-1 regulated sites from other EBV genes ZIIIA, B, and ZRE1,2,3,5 are shown in comparison to a consensus AP-1 site in the lower portion of the figure. Similarly, in the lower portion of the figure the putative binding site for CREB is shown in the BALF-2 minimal promoter in comparison to Col8, a cAMP response element shown to bind CREB1 cAMP site binding protein with high affinity and ZII, a site in the BZLF-1 promoter shown experimentally to respond to cAMP. Also in the lower portion of the figure, a site in the BALF-2 minimal promoter matching the Sp1 transcription factor consensus is shown, similar but not identical to Sp1 binding sites confirmed to exist in the EBV terminal repeats (Figure 2).
Figure 6. The hypothesis that a herpes DBP-like protein and RAG-1 protein have a modular architecture with structural and functional homology of functions is presented.Primordial RAG-1 protein (denoted pR1) has a carboxyl region structurally similar to a transib transposase (denoted T for Transib-like region structure #1), but extra amino terminus protein sequences that may be derived from another protein family (denoted N). Herpes DBP are magnesium dependent recombinases are also modular proteins with an amino terminal regulatory region (denoted N), and a carboxyl terminus that binds to DNA. The RAG-1 protein currently requires a physical association with the RAG-2 protein for recombinase activity in vivo, but may have initially exhibited recombinase properties without RAG-2 analogous to the DBP. As discussed in the text, primordial RAG-2 protein (denoted pR2) may initially have blocked the recombinase functions of pR1 but exposed immunologic determinants essential to herpes virus immunity since the DBP are a major herpes virus antigen. Both Herpes DBP and RAG-1 also require an association with host cell factors such as DNApk and ku shared with the RAG proteins for viral recombinase activity in vivo as discussed in more detail in the text.
Figure 7. Summary of functional correlates between RAG-1 and herpes DBP (asterix indicates observations novel to this work, other observations presented previously).These functional correlates are consistent with a homologous descent of both proteins from a common precursor recombinase although analogous convergence of functional properties cannot be excluded.
Figure 8. Conserved Functional DDE residues between transposases, RAG proteins and herpes DBP.Despite primary “low information content” amino acid sequence divergence of intervening sequences, RAG-1 proteins encode a “high information content” absolutely conserved E residue adjacent to a conserved alpha helix in the extreme carboxyl terminus of the protein shared with prokaryotic transposons (Tn5 and Tn10). This functionally conserved residue is required for RAG-1 magnesium ion binding and protein function. Similarly, despite primary amino acid sequence divergence of intervening regions all herpes DBP encode a conserved D/E residue adjacent to a conserved alpha helix in the DNA-binding carboxyl terminus of the protein. These high information content similarities are consistent with and support descent of both proteins from a common precursor recombinase.
Figure 9. Putative magnesium ion binding regions of the DBP can be localized adjacent to the DNA binding groove of the ICP-8 protein structure.The partial crystal structure of herpes simplex DBP ICP-8 is shown with experimentally determined DNA binding groove shown, while experimentally determined structures of RAG proteins and other herpes DBP are not solved currently. A black double arrow illustrates the experimentally determined DNA binding groove of ICP-8, while a green arrow indicates the hypothetical position of a bound magnesium ion in ICP-8 as localized by conserved blocks of D and E residues shared with RAG-1 in regions of ICP-8 (Figure 8). This alignment shows that the predicted Mg binding site geometry of ICP-8 is in proximity to the bound DNA as in other structurally characterized DDE enzymes such as RISC. These structural similarities are consistent with and support descent of DBP and RISC proteins from a common precursor DDE recombinase.
Figure 10. Possible scenarios for origins of V(D)J recombination in the absence of a “RAG Transposon.”The co-regulatory hypothesis presented in this work cannot exclude the possibility that a transib transposon-like element inserted directly into the current RAG locus adjacent to a primordial RAG-2 gene and a conveniently located independent N terminal-like protein with sequences somatically regulated in immune cells already present at the site as shown in the top scenario (Scenario 1). However, this scenario would require several independent coincidences of adjacent N protein and regulatory sequences adjacent to proto RAG2 not found experimentally. Scenario 1 also provides no explanation for the continued presence of the RAG-1/RAG-2-like locus in the modern sea urchin genome in the absence of any known function or slective advantage. In a more probable scenario shown in the bottom panel a herpes-like episome already containing N terminal protein sequences and cis-linked somatic regulatory sequences inserted adjacent to a primordial RAG-2 protein to generate the current RAG site (Scenario 2). After the initial generation of the RAG site in either scenario, the initial selective benefit of the RAG locus may have been to provide immunity to subsequent herpes virus infection rather than V(D)J recombination for an undetermined interval of time during which herpes and RAG protein primary sequences diverged, and this locus may still provide some partial immunity until the present time to conserved “high-information content” regions of the herpes recombinase that cannot diverge due to functional constraints . After the primordial herpes virus lineage had diverged sufficiently in primary sequence to permit re-infection of the primordial deuterostome host with herpes-like pathogens, resumption of the herpes-host arms race would continue until the present.
Agrawal,
Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system.
1998, Pubmed
Agrawal,
Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system.
1998,
Pubmed
Balmelle,
Developmental activation of the TCR alpha enhancer requires functional collaboration among proteins bound inside and outside the core enhancer.
2004,
Pubmed
Brandt,
G.O.D.'s Holy Grail: discovery of the RAG proteins.
2008,
Pubmed
Carey,
Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA.
1992,
Pubmed
Chatterji,
New concepts in the regulation of an ancient reaction: transposition by RAG1/RAG2.
2004,
Pubmed
Chen,
A dominant mutant form of the herpes simplex virus ICP8 protein decreases viral late gene transcription.
1996,
Pubmed
Chowdhury,
Genomic termini of equine herpesvirus 1.
1990,
Pubmed
Dardari,
Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138.
2001,
Pubmed
Delecluse,
The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.
2000,
Pubmed
Dreyfus,
Evidence suggesting an evolutionary relationship between transposable elements and immune system recombination sequences.
1992,
Pubmed
Dreyfus,
Comparative analysis of invertebrate Tc6 sequences that resemble the vertebrate V(D)J recombination signal sequences (RSS).
1999,
Pubmed
Dreyfus,
Asymmetric DDE (D35E)-like sequences in the RAG proteins: implications for V(D)J recombination and retroviral pathogenesis.
1999,
Pubmed
Dreyfus,
Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.
2005,
Pubmed
Dreyfus,
The DDE recombinases: diverse roles in acquired and innate immunity.
2006,
Pubmed
Dreyfus,
Epstein-Barr virus infection of T cells: implications for altered T-lymphocyte activation, repertoire development and autoimmunity.
1996,
Pubmed
Dyda,
Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases.
1994,
Pubmed
Feschotte,
DNA transposons and the evolution of eukaryotic genomes.
2007,
Pubmed
Feschotte,
Transposable elements and the evolution of regulatory networks.
2008,
Pubmed
Finkel,
T-cell development and transmembrane signaling: changing biological responses through an unchanging receptor.
1991,
Pubmed
Francis,
Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency.
1997,
Pubmed
Fugmann,
An ancient evolutionary origin of the Rag1/2 gene locus.
2006,
Pubmed
,
Echinobase
Gellert,
V(D)J recombination: RAG proteins, repair factors, and regulation.
2002,
Pubmed
Gladow,
Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors.
2004,
Pubmed
Hah,
Induction of peripheral tolerance in dual TCR T cells: an evidence for non-dominant signaling by one TCR.
2005,
Pubmed
Hammerschmidt,
DNA replication of herpesviruses during the lytic phase of their life-cycles.
1990,
Pubmed
Han,
Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells.
1996,
Pubmed
Hiom,
DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocations.
1998,
Pubmed
Hung,
Characterization of the Epstein-Barr virus BALF2 promoter.
1999,
Pubmed
Jones,
A Ku bridge over broken DNA.
2001,
Pubmed
Jones,
The taming of a transposon: V(D)J recombination and the immune system.
2004,
Pubmed
Kapitonov,
RAG1 core and V(D)J recombination signal sequences were derived from Transib transposons.
2005,
Pubmed
,
Echinobase
Kolman,
Marked variation in the size of genomic plasmids among members of a family of related Epstein-Barr viruses.
1992,
Pubmed
Kolman,
Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.
1996,
Pubmed
Kuhn-Hallek,
Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells.
1995,
Pubmed
Liu,
Argonaute2 is the catalytic engine of mammalian RNAi.
2004,
Pubmed
Lu,
Amino acid residues in Rag1 crucial for DNA hairpin formation.
2006,
Pubmed
Lu,
Understanding how the V(D)J recombinase catalyzes transesterification: distinctions between DNA cleavage and transposition.
2008,
Pubmed
Makhov,
Two-dimensional crystallization of herpes simplex virus type 1 single-stranded DNA-binding protein, ICP8, on a lipid monolayer.
2004,
Pubmed
Mapelli,
The crystal structure of the herpes simplex virus 1 ssDNA-binding protein suggests the structural basis for flexible, cooperative single-stranded DNA binding.
2005,
Pubmed
Melek,
Effect of HIV integrase inhibitors on the RAG1/2 recombinase.
2002,
Pubmed
Menetski,
V(D)J recombination activity in lymphoid cell lines is increased by agents that elevate cAMP.
1990,
Pubmed
Miller,
Lytic cycle switches of oncogenic human gammaherpesviruses.
2007,
Pubmed
Moody,
Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergence.
2003,
Pubmed
Oettinger,
How to keep V(D)J recombination under control.
2004,
Pubmed
Paramita,
Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
2007,
Pubmed
Pritham,
Mavericks, a novel class of giant transposable elements widespread in eukaryotes and related to DNA viruses.
2007,
Pubmed
Reddy,
Genomic instability due to V(D)J recombination-associated transposition.
2006,
Pubmed
Schatz,
Antigen receptor genes and the evolution of a recombinase.
2004,
Pubmed
Shih,
Inverse transposition by the RAG1 and RAG2 proteins: role reversal of donor and target DNA.
2002,
Pubmed
Song,
Crystal structure of Argonaute and its implications for RISC slicer activity.
2004,
Pubmed
Song,
Argonaute and RNA--getting into the groove.
2006,
Pubmed
Spain,
The locus of Epstein-Barr virus terminal repeat processing is bound with enhanced affinity by Sp1 and Sp3.
1997,
Pubmed
Spanopoulou,
The homeodomain region of Rag-1 reveals the parallel mechanisms of bacterial and V(D)J recombination.
1996,
Pubmed
Srinivas,
Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2.
1995,
Pubmed
Srinivas,
Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line.
1998,
Pubmed
Sun,
Sp1 binds to the precise locus of end processing within the terminal repeats of Epstein-Barr virus DNA.
1997,
Pubmed
Swanson,
Full-length RAG-2, and not full-length RAG-1, specifically suppresses RAG-mediated transposition but not hybrid joint formation or disintegration.
2004,
Pubmed
Taylor,
C-terminal region of herpes simplex virus ICP8 protein needed for intranuclear localization.
2003,
Pubmed
Taylor,
Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8.
2004,
Pubmed
Tonegawa,
Somatic generation of antibody diversity.
1983,
Pubmed
Tsai,
Regulation of RAG1/RAG2-mediated transposition by GTP and the C-terminal region of RAG2.
2003,
Pubmed
Uprichard,
Conformational changes in the herpes simplex virus ICP8 DNA-binding protein coincident with assembly in viral replication structures.
2003,
Pubmed
Verkoczy,
The scope of receptor editing and its association with autoimmunity.
2004,
Pubmed
Verkoczy,
A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes.
2005,
Pubmed
Wagner,
Peripheral blood lymphocytes express recombination-activating genes 1 and 2 during Epstein-Barr virus-induced infectious mononucleosis.
2004,
Pubmed
Zhou,
Association of herpes simplex virus type 1 ICP8 and ICP27 proteins with cellular RNA polymerase II holoenzyme.
2002,
Pubmed
Zimmermann,
Structure and role of the terminal repeats of Epstein-Barr virus in processing and packaging of virion DNA.
1995,
Pubmed
de Bruyn Kops,
Preexisting nuclear architecture defines the intranuclear location of herpesvirus DNA replication structures.
1994,
Pubmed
van Gent,
Similarities between initiation of V(D)J recombination and retroviral integration.
1996,
Pubmed